Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 18, 2017

View Archived Issues

TG Therapeutics reports outcome from FDA meeting on GENUINE trial of ublituximab

APBA3 and MCF2 gene methylation status to predict psychotherapy response in BPD

Pembrolizumab shows activity in phase II study in thymic epithelial tumors

Bayer submits marketing authorization application for BAY-94-9027 in Japan

Preclinical and clinical results presented for poziotinib in the treatment of NSCLC

Charleston Laboratories resubmits CL-108 NDA

Biosimilar GP-2017 shows efficacy similar to adalimumab in psoriasis patients

Xenon Pharmaceuticals begins phase I study of XEN-1101

Amneal Pharmaceuticals and Impax Laboratories announce merger

Takeda and HemoShear partner to discover and develop novel therapeutics for liver diseases

Teva submits BLA in U.S. for fremanezumab

Promentis studies safety of SXC-2023 in healthy volunteers in new phase I trial

Ignyta's entrectinib obtains PRIME designation from EMA

FDA clears Incysus's IND for gamma-delta T-cell immunotherapy

Merck KGaA presents novel cyclophilin inhibitors

Mutabilis joins ENABLE project

ProMIS Neurosciences' AD candidate selectively binds to amyloid beta oligomers

Gemini Therapeutics completes series A financing

ACY-241 in combination with nivolumab shows antitumoral activity in refractory NSCLC

Mitsubishi Tanabe Pharma identifies new CYP450 11B2 inhibitors

Tonix Pharmaceuticals gives update on Tonmya CMC guidance meeting with FDA

Novel griseofulvin derivatives discovered by Daiichi Sankyo

Acticor Biotech reaches agreement on phase I study of ACT-107

Cue Biopharma describes novel 4-1BBL variant immunomodulatory polypeptides

New twist-related protein 1 vaccines patented by Asahikawa Medical University

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...